Breast Lobular Carcinoma — Trials

Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04551495	Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)(ROSALINE)	unknown	Phase 2	65	Jules Bordet InstituteOTHER	2	Dec 4, 2024	clinicaltrials
NCT05868252	Molecular Analysis of the Sloane Project	unknown	—	1,500	King's College LondonOTHER	1	May 22, 2023	clinicaltrials